A broad-based and diverse translational research program that is collaborative, multidisciplinary, and interrelated requires specific administrative leadership and support to be successful. The University of Michigan Head and Neck SPORE consists of an ambitious, highly integrated and synergistic program of four major research projects, and a comprehensive program for selection, support and evaluation of pilot research projects and career development awards. Our Administrative Core has been a very successful shared resource that maintains the focus on the translational goals, institutional commitment and adequate infrastructure support for clinical / basic science integrated efforts. The DM H&N SPORE Administration and Translational Trials Support Core has committed significant resources for program organization, coordination, data management, community outreach, computer support and management services necessary to link each project and achieve overall SPORE goals. This Core acts as a central information clearinghouse, and provides organization for all meetings, budgets, financial reporting, data management, quality control, activity reports, problem solving, scientific leadership, and solicitation of new ideas and faculty. Oversight of day-to-day operations of the Tissue Core is provided by this Core and collaborative efforts between all core resources and SPORE projects is facilitated in this office. Patient Advocate activities and initiatives with community physicians in the SPORE Network are coordinated by this Core. The Core is responsible for program evaluation, recruitment and support of Internal and External reviewers, and administrative support and evaluation of the Developmental Research and Career Development Programs. Gregory T. Wolf, M.D., Chair of Otolaryngology- Head and Neck Surgery functions as PI and is responsible for planning and implementation, reporting and assessment of all aspects of the SPORE Program. He has extensive experience in multidisciplinary translational research. The Core is organized to maximize oversight, investigator support, enhance patient care, and electronic data management through the use of formal seminars, meetings and reports. To ensure success, he has committed significant effort (20%) to this Core. The operation of this Core enhances and facilitates the unqualified success of this SPORE effort and thereby has a direct, favorable impact on the treatment, morbidity and mortality of head and neck cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA097248-10
Application #
8382525
Study Section
Special Emphasis Panel (ZCA1-GRB-I)
Project Start
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
10
Fiscal Year
2012
Total Cost
$532,211
Indirect Cost
$87,644
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Matsumoto, Camila S; Almeida, Luciana O; Guimarães, Douglas M et al. (2016) PI3K-PTEN dysregulation leads to mTOR-driven upregulation of the core clock gene BMAL1 in normal and malignant epithelial cells. Oncotarget 7:42393-42407
Pearson, Alexander T; Finkel, Kelsey A; Warner, Kristy A et al. (2016) Patient-derived xenograft (PDX) tumors increase growth rate with time. Oncotarget 7:7993-8005
Arthur, Anna E; Bellile, Emily L; Rozek, Laura S et al. (2016) Pretreatment serum xanthophyll concentrations as predictors of head and neck cancer recurrence and survival. Head Neck 38 Suppl 1:E1591-7
Walline, Heather M; Komarck, Christine M; McHugh, Jonathan B et al. (2016) Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma. Mol Cancer Res 14:941-952
Walline, Heather M; Carey, Thomas E; Goudsmit, Christine M et al. (2016) High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res :
Choi, Seung Hee; Terrell, Jeffrey E; Bradford, Carol R et al. (2016) Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients? Nicotine Tob Res :
Zhang, Yanxiao; Koneva, Lada A; Virani, Shama et al. (2016) Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures. Clin Cancer Res 22:4735-45
Rudy, Shannon F; Brenner, J Chad; Harris, Jennifer L et al. (2016) In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model. J Otolaryngol Head Neck Surg 45:26
Swiecicki, Paul L; Bellile, Emily; Sacco, Assuntina G et al. (2016) A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer. Invest New Drugs 34:481-9
Prince, Victoria; Bellile, Emily L; Sun, Yilun et al. (2016) Individualized risk prediction of outcomes for oral cavity cancer patients. Oral Oncol 63:66-73

Showing the most recent 10 out of 233 publications